Duessoldorf, Germany (June 5)–The supervisory board of Degussa GmbH named Patrik Wohlhauser, currently head of the exclusive synthesis & catalysts business unit, as an executive director of
Degussa GmbH. From July 1, 2007, his new responsibilities will include, among others, the new international sales function
of RAG's subsidiary Degussa. Wohlhauser will also be the management board member responsible for the Consumer Solutions reporting
segment and for the Western and Eastern Europe regions. His successor as head of the exclusive synthesis & catalysts business
unit will be Rudolf Hanko, who currently heads the exclusive synthesis business line of the same business unit.
San Diego, CA (June 5)–Cadence Pharmaceuticals, Inc appointed Catherine J. Hardalo, MD, vice-president of clinical development. Hardalo joins the company from Schering-Plough
Research Institute, where she directed the clinical development of antimicrobial products.
San Diego, CA (June 4)–Carol G. Gallagher was promoted to senior vice-president of corporate development and commercial affairs with Anadys Pharmaceuticals, Inc. Gallagher joined the company as vice-president of commercial affairs in April 2006. She previously served as vice-president
of sales, marketing, and product planning at CancerVax Corporation and senior director of oncology marketing at Biogen Idec,
Emeryville, CA (May 31)–Bionovo, Inc. named Rob Frankenberg, PhD, vice-president of drug manufacturing. Frankenberg joins the company after serving in various
positions with Bayer HealthCare.
Mississauga, ON, Canada (May 29)–Draxis Pharma named Bruce DeChambre vice-president of commercial and business development. DeChambre previously was vice-president of
sales and marketing at SAB-Pharma. He also held positions at Abraxis Pharmaceutical, Fujisawa USA, Inc., and Baxter Healthcare
Irvine, CA (May 29)–Timothy P. Walbert was named chief executive officer of IDM Pharma. Walbert previously was executive vice-president, commercial operations with NeoPharm, Inc.
Indianapolis, IN (May 25)–Eli Lilly and Co. promoted Frank Deane to president of manufacturing. Deane is currently vice-president of quality. He joined Lilly in 1979
at the company's manufacturing operations in Kinsale, Ireland.
Burlington, MA (May 24)–Robert M. Haggerty was appointed vice-president of quality with Hyaluron Contract Manufacturing. Haggerty served as director of quality assurance at Alexion Pharmaceuticals and held various positions at Ben Venue, Dupont,
and Transkaryotic Therapies.